Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic study
Chiara Fabbri, Siegfried Kasper, Joseph Zohar, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 104, pp. 110050-110050
Closed Access | Times Cited: 25

Showing 25 citing articles:

Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: A systematic review and meta-analysis
Vincenzo Oliva, Matteo Lippi, Riccardo Paci, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 109, pp. 110266-110266
Closed Access | Times Cited: 114
Transcriptome-wide association study of treatment-resistant depression and depression subtypes for drug repurposing
Chiara Fabbri, Oliver Pain, Saskia P. Hagenaars, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 10, pp. 1821-1829
Open Access | Times Cited: 36
Inhibition of PDK3 by artemisinin, a repurposed antimalarial drug in cancer therapy
Saleha Anwar, Debarati DasGupta, Naved Azum, et al.
Journal of Molecular Liquids (2022) Vol. 355, pp. 118928-118928
Closed Access | Times Cited: 22
The Role of Glutamate Underlying Treatment-resistant Depression
Jeongseop Kim, Tae-Eun Kim, Seung‐Hwan Lee, et al.
Clinical Psychopharmacology and Neuroscience (2023) Vol. 21, Iss. 3, pp. 429-446
Open Access | Times Cited: 13
The ROCK Inhibitor Fasudil and Sertraline Share Morphological and Molecular Effects in the Hippocampus of Chronically Stressed Rats: Exploring Common Antidepressant Pathways by Network Pharmacology
Gonzalo García‐Rojo, Ignacio Martı́nez, Felipe I. Aguayo, et al.
ACS Pharmacology & Translational Science (2025)
Closed Access
Mechanisms and Molecular Targets of Artemisinin in Cancer Treatment
Dongning Li, Jie Zhang, Xiaoyan Zhao
Cancer Investigation (2021) Vol. 39, Iss. 8, pp. 675-684
Closed Access | Times Cited: 26
Understanding treatment-resistant depression using “omics” techniques: A systematic review
Nare Amasi-Hartoonian, Carmine M. Pariante, Annamaria Cattaneo, et al.
Journal of Affective Disorders (2022) Vol. 318, pp. 423-455
Open Access | Times Cited: 18
Targeting the Renin-Angiotensin System (RAS) for Neuropsychiatric Disorders
Aline Silva de Miranda, Danielle S. Macêdo, Natália Pessoa Rocha, et al.
Current Neuropharmacology (2022) Vol. 22, Iss. 1, pp. 107-122
Open Access | Times Cited: 17
Efficacy and Safety of Antidiabetic Agents for Major Depressive Disorder and Bipolar Depression: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials
Jian Zhang, Rongyi Sun, Yang Cai, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 4, pp. 1172-1172
Open Access | Times Cited: 3
Drug Repurposing for the Management of Depression: Where Do We Stand Currently?
Hosna Mohammad Sadeghi, Ida Adeli, Taraneh Mousavi, et al.
Life (2021) Vol. 11, Iss. 8, pp. 774-774
Open Access | Times Cited: 21
Treatment-resistant bipolar depression: concepts and challenges for novel interventions
Alexandre Paim Díaz, Brisa S. Fernandes, João Quevedo, et al.
Brazilian Journal of Psychiatry (2021) Vol. 44, Iss. 2, pp. 178-186
Open Access | Times Cited: 16
Non-canonical pathways in the pathophysiology and therapeutics of bipolar disorder
Rodrigo Machado‐Vieira, Alan C. Courtes, Carlos A. Zarate, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 6
Real-world outcomes of concomitant antidepressant and statin use in primary care patients with depression: a population-based cohort study
Riccardo De Giorgi, Franco De Crescenzo, Philip J. Cowen, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 5
From the Drugbank Application to the Novel Drugs: A Pharmacogenomic Summary
Setya Rini Abiyana, Setiyo Budi Santoso, Prasojo Pribadi, et al.
E3S Web of Conferences (2024) Vol. 500, pp. 04002-04002
Open Access | Times Cited: 1
Exploring the potential of drug repurposing for treating depression
Chaitenya Verma, Kritika Jain, Ashok Saini, et al.
Progress in molecular biology and translational science (2024), pp. 79-105
Closed Access | Times Cited: 1
Molecular Mechanisms Associated with Antidepressant Treatment on Major Depression
Lívia Ramos-da-Silva, Pamela T. Carlson, Lícia C. Silva-Costa, et al.
Complex Psychiatry (2021) Vol. 7, Iss. 3-4, pp. 49-59
Open Access | Times Cited: 10
Statins in depression: a repurposed medical treatment can provide novel insights in mental health
Riccardo De Giorgi, Philip J. Cowen, Catherine J. Harmer
International Review of Psychiatry (2022) Vol. 34, Iss. 7-8, pp. 699-714
Open Access | Times Cited: 7
Investigation of Psychoactive Medications: Challenges and a Practical and Scalable New Path
Dekel Taliaz, Alessandro Serretti
CNS & Neurological Disorders - Drug Targets (2022) Vol. 22, Iss. 9, pp. 1267-1274
Closed Access | Times Cited: 4
The anti-anxiety/depression effect of a combined complex of casein hydrolysate and γ-aminobutyric acid on C57BL/6 mice
Lei Cai, Qian Tao, Wenzhi Li, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 4
Prospects for personalization of depression treatment with genome sequencing
Małgorzata Borczyk, Marcin Piechota, Jan Rodriguez Parkitna, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 17, pp. 4220-4232
Closed Access | Times Cited: 4
Strategy for Cysteine-Targeting Covalent Inhibitors Screening using In-house Database based LC-MS/MS and Drug Repurposing
Xiaolan Hu, Jian‐Lin Wu, Quan He, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 15, Iss. 3, pp. 101045-101045
Open Access
Microglia Sing the Prelude of Neuroinflammation-Associated Depression
Qingqing Li, Ying Xie, Jinyi Lin, et al.
Molecular Neurobiology (2024)
Closed Access
Microarrays and NGS for Drug Discovery
Laura Pop, Oana Zănoagă, Paul Chiroi, et al.
IntechOpen eBooks (2021)
Open Access | Times Cited: 2
Pharmakotherapie: Allgemeine Aspekte
Martin E. Keck
Elsevier eBooks (2022), pp. 143-147
Closed Access
An interview with Dr Chiara Fabbri: pharmacogenomics and drug repurposing for treatment-resistant depression
Chiara Fabbri
Pharmacogenomics (2021) Vol. 22, Iss. 17, pp. 1107-1109
Closed Access
Page 1

Scroll to top